Søren Lemonius

Søren Lemonius is currently a Director-Executive Board at Evolva SA, Director at Sunstone LSV General Partner I ApS, Director at Galecto Biotech ApS, Director at Sunstone LSV Special Limited Partner II Aps, Director at P, Director at Sunstone LSV Management A, Director at Sunstone LSV Special LP II Holding Aps, Director at Sunstone LSV Gp I Holding ApS, Director at Sunstone Lsv Partners & Co. Holding ApS, Director at Sunstone Lsv Partners Holding ApS, Director at Sunstone LSV General Partner BI ApS, Director at Sunstone LSV GP BI Holding ApS, Managing Director at Betterinvest ApS, Managing Director at Sunstone LSV & Co. Special Limited Partner III Holding ApS, and Director at Synendos Therapeutics AG.
He previously held positions such as Chairman at Biomonitor ApS, Chairman at TD Vaccines A, Investment Director at Danmarks Eksport- og Investeringsfond, Director at Euro-Diagnostica AB, Director at Atonomics A, Independent Director at Nuevolution AB, Director at Chempaq A, Director at Symphogen A, Director at Evolva Biotech A, Director at Nuevolution A, Managing Director at Sunstone LSV Partners & Co. Holding III ApS, Managing Director at Sunstone LSV Partners Holding III ApS, Managing Director at Sunstone LSV Invest III Holding ApS, Managing Director at Sunstone LSV Invest III ApS, Managing Director at Sunstone LSV Special Limited Partner III Aps, Director at Chempaq Patent Holding ApS, Director at Sunstone Lsv Special Ltd. Partner Iii Holding Aps, and Director at Galecto, Inc. He also worked as an Innovation Manager at Foss Analytical A and as a Chief Technology Officer at Strategic Investments A. Mr. Lemonius received an undergraduate degree from the University of Southern Denmark.